Tyrosine specific protein kinases are encoded by certain retrovirus transforming genes, such as the src gene of Rous sarcoma virus. These proteins are believed to transform by phosphorylating specific cellular components. The overall objective of this project is to determine if protein phosphorylation at tyrosine is necessary for transformation and to identify those cellular targets which have a significant role in transformation. Three different approaches will be used. The initial part of this work is concerned with the characterization of the proteins phosphorylated at tyrosine in cells transformed by different retroviruses or infected by retrovirus vectors carrying the cellular homologs of these genes. The objectives of these initial studies are to determine whether changes in substrate specificity are associated with the ability to transform, whether transforming proteins with partial homology to the RSV src gene also have associated kinase activity, and whether phosphorylation at tyrosine modifies the function of the phosphorylated polypeptide. Second, protein phosphorylation at serine in retrovirus transformed cells will be characterized in order to examine the hypothesis that serine phosphorylation represents a secondary event which mediates some of the actions of viral tyrosine kinases. The activity of the Ca++- and phospholipid-dependent protein kinase C in retrovirus-transformed cells will be examined in order to determine if this enzyme is involved in transformation. Third, cellular mutants with altered susceptibility to retrovirus transforming proteins will be isolated in order to define cellular genes whose products interact directly with retrovirus transforming proteins. Transformed cells will be selected from cell lines infected by RSV mutants that carry partial or conditional defects in the src gene. If cellular mutants in which the viral defect is suppressed by a cellular mutation can be identified, DNA transfer experiments will be carried out to determine if isolation of these genes by molecular cloning is feasible.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA017542-14
Application #
3164724
Study Section
Experimental Virology Study Section (EVR)
Project Start
1978-12-01
Project End
1989-11-30
Budget Start
1988-12-01
Budget End
1989-11-30
Support Year
14
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of California Berkeley
Department
Type
Schools of Arts and Sciences
DUNS #
094878337
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Gottlieb-Abraham, Efrat; Shvartsman, Dmitry E; Donaldson, John C et al. (2013) Src-mediated caveolin-1 phosphorylation affects the targeting of active Src to specific membrane sites. Mol Biol Cell 24:3881-95
Rodriguez, Elena M; Dunham, Elizabeth E; Martin, G Steven (2009) Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells. J Cell Physiol 221:171-82
Shvartsman, Dmitry E; Donaldson, John C; Diaz, Begona et al. (2007) Src kinase activity and SH2 domain regulate the dynamics of Src association with lipid and protein targets. J Cell Biol 178:675-86
Zhu, Qingwei; Krakowski, Ariel R; Dunham, Elizabeth E et al. (2007) Dual role of SnoN in mammalian tumorigenesis. Mol Cell Biol 27:324-39
Jackson, William T; Martin, G Steven (2006) Transcription of the Schizosaccharomyces pombe gene cdc18+: roles of MCB elements and the DSC1 complex. Gene 369:100-8
Prathapam, Tulsiram; Tegen, Sarah; Oskarsson, Thordur et al. (2006) Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition. Proc Natl Acad Sci U S A 103:2695-700
Berdeaux, Rebecca L; Diaz, Begona; Kim, Lomi et al. (2004) Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function. J Cell Biol 166:317-23
Martin, G Steven (2004) The road to Src. Oncogene 23:7910-7
He, Jun; Tegen, Sarah B; Krawitz, Ariel R et al. (2003) The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins. J Biol Chem 278:30540-7
Webb, Brian L; Diaz, Begona; Martin, G Steven et al. (2003) A reporter system for reverse transfection cell arrays. J Biomol Screen 8:620-3

Showing the most recent 10 out of 43 publications